Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Novel Non-Invasive Liver Fibrosis Tests Are Effective Biopsy Alternatives
February 2026
Novel non-invasive liver disease assessments (NILDAs) are effective liver biopsy alternatives for fibrosis, a 2026 systematic review has found.
Read more
9
Mins
8 Jun 2017
Hepatocellular Carcinoma. Part 2: Clinical Presentation and Diagnosis
Clinical presentation of hepatocellular carcinoma (HCC) can vary from asymptomatic patients to patients presenting variable symptoms such as pain, lethargy…
2
Mins
8 Jun 2017
Predicting Severe Liver Disease in the General Population: Abdominal Obesity, Insulin Resistance, Diabetes, Cholesterol, and Alcohol
Liver disease is the 13th leading cause of death worldwide, and hepatocellular carcinoma is the 2nd leading cause of cancer death. Finland has one of the…
11
Mins
8 Jun 2017
Hepatocellular Carcinoma. Part 3: Surgical and Medical Treatment
Hepatocellular carcinoma (HCC) treatment is variable and depends on the size, location, and presence of extra hepatic metastasis and vascular invasion.
1
Mins
8 Jun 2017
Japanese Guidelines and Real-World Data on the Management of Hepatitis C
The guideline committee of the Japan Society of Hepatology (JSH) have promptly updated the treatment guideline for the hepatitis C virus (HCV) after…
9
Mins
8 Jun 2017
A Look at Platelet Count in Chronic Hepatitis C Infection
Many complications can occur during the evolution of chronic Hepatitis C virus (HCV) infection. Some of them can be…
2
Mins
8 Jun 2017
What is the Role of Ursodeoxycholic Acid for the Future Management of Patients with Primary Sclerosing Cholangitis in the Clinic and in Trials?
Primary sclerosing cholangitis (PSC) is a rare, progressive, cholestatic, immune-mediated hepatobiliary disease. It is characterised by inflammation…
2
Mins
8 Jun 2017
Hepatitis E Virus Infection and Acute Non-Traumatic Neurological Injury
Hepatitis E virus (HEV) is endemic in many developed countries, with seroprevalence rates ranging from 4.7% in Scotland to 31.1% in France. Cases are…
2
Mins
8 Jun 2017
Clinical Hepatocyte Cell Therapy: Challenges and Opportunities
The clinical application of hepatocyte transplants to treat patients with liver disease extends back to the early 1990s. Hepatocyte transplants are…
Loading posts...
« Previous
1
…
61
62
63
64
65
…
76
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View